The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral abdominal wall hernia.
It was reported that after implant, the patient experienced recurrence, areas of seropurulent fluid encountered while approaching mesh, extensive scarring and adhesions of mesh to abdominal wall, infected mesh as well as pain.
Post-operative patient treatment included repair of recurrent ventral incisional hernia, removal of infected mesh, recurrent large ventral epigastric hernia repair with mesh, and insertion of pain pump.
|